Log in
Enquire now
‌

US Patent 11207403 Human cytomegalovirus immunogenic composition

Patent 11207403 was granted and assigned to Sanofi Pasteur on December, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

The invention relates to an immunogenic composition comprising an HCMV gH/gL/UL128/UL130/UL131 pentameric complex antigen and a TH1-inducing adjuvant. It further relates to the immunogenic composition for use as an HCMV vaccine.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11207403 Human cytomegalovirus immunogenic composition

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.